{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-10-09",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "product_ndc": "22840-1636",
      "generic_name": "Bipolaris sorokiniana",
      "labeler_name": "Greer Laboratories, Inc.",
      "brand_name": "Bipolaris sorokiniana",
      "active_ingredients": [
        {
          "name": "COCHLIOBOLUS SATIVUS",
          "strength": ".01 g/mL"
        }
      ],
      "finished": true,
      "packaging": [
        {
          "package_ndc": "22840-1636-1",
          "description": "5 mL in 1 VIAL, MULTI-DOSE (22840-1636-1)",
          "marketing_start_date": "19810915",
          "sample": false
        }
      ],
      "listing_expiration_date": "20261231",
      "openfda": {},
      "marketing_category": "BLA",
      "dosage_form": "SOLUTION",
      "spl_id": "36ac182a-ff48-50a9-e063-6394a90aa917",
      "product_type": "NON-STANDARDIZED ALLERGENIC",
      "route": [
        "INTRADERMAL",
        "PERCUTANEOUS",
        "SUBCUTANEOUS"
      ],
      "marketing_start_date": "19810915",
      "product_id": "22840-1636_36ac182a-ff48-50a9-e063-6394a90aa917",
      "application_number": "BLA101833",
      "brand_name_base": "Bipolaris sorokiniana",
      "pharm_class": [
        "Allergens [CS]",
        "Cell-mediated Immunity [PE]",
        "Fungal Proteins [CS]",
        "Increased Histamine Release [PE]",
        "Increased IgG Production [PE]",
        "Non-Standardized Fungal Allergenic Extract [EPC]"
      ]
    }
  ]
}